Chong Kun Dang Pharmaceutical - Asset Resilience Ratio

Latest as of September 2025: 0.80%

Chong Kun Dang Pharmaceutical (185750) has an Asset Resilience Ratio of 0.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Chong Kun Dang Pharmaceutical debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩12.13 Billion

≈ $8.22 Million USD Cash + Short-term Investments

Total Assets

₩1.52 Trillion

≈ $1.03 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Chong Kun Dang Pharmaceutical's Asset Resilience Ratio has changed over time. See Chong Kun Dang Pharmaceutical book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Chong Kun Dang Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Chong Kun Dang Pharmaceutical market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩12.13 Billion	0.8%
Total Liquid Assets	₩12.13 Billion	0.80%

Asset Resilience Insights

Limited Liquidity: Chong Kun Dang Pharmaceutical maintains only 0.80% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Chong Kun Dang Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Chong Kun Dang Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Chong Kun Dang Pharmaceutical (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Chong Kun Dang Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	5.05%	₩73.70 Billion ≈ $49.95 Million	₩1.46 Trillion ≈ $988.58 Million	-5.32pp
2023-12-31	10.37%	₩145.42 Billion ≈ $98.55 Million	₩1.40 Trillion ≈ $950.41 Million	+6.95pp
2022-12-31	3.42%	₩38.44 Billion ≈ $26.05 Million	₩1.12 Trillion ≈ $762.32 Million	-1.89pp
2021-12-31	5.30%	₩55.52 Billion ≈ $37.63 Million	₩1.05 Trillion ≈ $709.33 Million	+1.27pp
2020-12-31	4.04%	₩38.20 Billion ≈ $25.89 Million	₩946.33 Billion ≈ $641.32 Million	+2.11pp
2019-12-31	1.93%	₩15.45 Billion ≈ $10.47 Million	₩801.35 Billion ≈ $543.06 Million	--

pp = percentage points

About Chong Kun Dang Pharmaceutical

KO:185750 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$765.24 Million

₩1.13 Trillion KRW

Market Cap Rank

#10377 Global

#308 in Korea

Share Price

₩85700.00

Change (1 day)

-1.38%

52-Week Range

₩78700.00 - ₩97700.00

All Time High

₩207617.05